Behind M&As in China and the United States: Networks, learning, and institutions
Access Status
Authors
Date
2011Type
Metadata
Show full item recordCitation
Source Title
ISSN
School
Collection
Abstract
Few scholars would dispute the argument that mergers and acquisitions (M&As) are different in China and the United States, but we know little about how they differ. This article reports one of the first studies that systematically compares and contrasts how M&As differ in these two countries. While prior research on M&As tends to emphasize economic and financial explanations while treating firms as atomistic actors severed from their institutional and network relations, we develop a new theoretical framework based on relational, behavioral, and institutional perspectives. We not only consider firms as learning actors embedded in network relations, but also compare and contrast their M&A patterns between China and the United States, two distinctive institutional contexts. We find that both a firm's structural hole position and its learning orientation (exploration/exploitation) in alliances have direct and joint impacts on subsequent M&As. Further, such impacts differ across the two countries, due to their institutional disparities.
Related items
Showing items related by title, author, creator and subject.
-
Mazzarol, Timothy W. (1997)The principal focus of the present study was to examine the factors critical to the development and maintenance of a competitive advantage for education institutions operating in international markets. International ...
-
Mohamad, Wardah (2010)The study of organizational strategy, structure and culture has been an area of interest for strategic management research. While there is abundant empirical research on strategic management in the West, little research ...
-
Brinkman, Sally; Sayers, M.; Goldfeld, S.; Kline, J. (2009)Username: Password: Search: Advanced searchHome Journals View All Journals Expert Opinion on Biological Therapy Drug Delivery Drug Discovery Drug Metabolism & Toxicology Drug Safety Emerging Drugs Investigational ...